Valeria R.
- Country
- Italy
- Department
- Scienze cliniche internistiche anestesiologiche e cardiovascolari
Research Overview
- A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with progressive systemic sclerosis
- Efficacy and Safety of Hydroxychloroquine in Early Systemic Sclerosis: A Double-Blind, Randomized, Placebo-Controlled, Add-On Trial
- Long-Term Safety and Efficacy of Subcutaneous Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease: An Open-Label Study
Data & Insights
Has run more than one trial at 12 of 89 partner sites.
Specializations
Pulmonary Medicine
This investigator specializes in treating interstitial lung disease, particularly in connection with systemic sclerosis. Their work focuses on evaluating therapeutic approaches to prevent decline in lung function and manage respiratory complications.
- Systemic Sclerosis-Associated ILD
- Bronchial Disease Management
- Pulmonary Function Assessment
Primary expertise centers on monitoring and measuring forced vital capacity changes in patients with progressive lung conditions.
Autoimmune Disorders
The investigator has developed significant expertise in treating systemic sclerosis, an autoimmune condition affecting multiple body systems. Their research encompasses both early-stage disease intervention and long-term management strategies.
- Early Systemic Sclerosis Treatment
- Immunological Abnormalities
- Vascular Complications
Special focus is placed on evaluating novel therapeutic approaches for managing autoimmune manifestations.
Therapeutic Innovation
The investigator explores various treatment modalities including biological therapies and antimalarial agents for systemic sclerosis management. Their work involves evaluating both established and experimental treatments.
- Belimumab Applications
- Hydroxychloroquine Studies
- Combined Therapy Approaches
Research includes assessment of treatment efficacy in combination with standard therapeutic protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.